Global Artificial Intelligence (AI) In Drug Discovery Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

9 Dec, 2021

Check out TBRC’s sale today for

The artificial intelligence (AI) in drug discovery market consists of sales of AI for drug discovery and related services. Artificial Intelligence for drug discovery is a technology that uses a simulation of human intelligence process by machines to tackle complex problems in the drug discovery process. It helps to find new molecules to identify drug targets and develop personalized medicines in the pharmaceutical industry.

Global Artificial Intelligence (AI) In Drug Discovery Market Size And Drivers:

The global AI in drug discovery market is expected to grow from $0.36 billion in 2020 to $0.47 billion in 2021 at a compound annual growth rate (CAGR) of 30.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The AI in drug discovery market is expected to reach $1.69 billion in 2025 at a CAGR of 38%. The rise in demand for a reduction in the overall time taken for the drug discovery process is a key driver propelling the growth of the artificial intelligence in drug discovery market.

Request For A Sample For The Global Artificial Intelligence (AI) In Drug Discovery Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

Trends In The Global Artificial Intelligence (AI) In Drug Discovery Market

Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market. For instance, in September 2019, Atomwise Inc. and Jiangsu Hansoh Pharmaceutical Group Co. Ltd announced the collaboration of $1.5 billion to design and discover the potential drug candidates for up to 11 undisclosed target proteins in cancer and other therapeutic areas. The collaboration is expected to combine Atomwise Inc’s AI technology, protein structure expertise, and medicinal chemistry with Jiangsu Hansoh Pharmaceutical Group Co. Ltd’s manufacturing, research & development, and commercial capabilities in order to improve and accelerate clinical development and drug discovery process.

Global Artificial Intelligence (AI) In Drug Discovery Market Segments:
The global artificial intelligence in drug discovery market is further segmented –
By Technology: Deep Learning, Machine Learning
By Drug Type: Small Molecule, Large Molecules
By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others
By End-Users: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Others
By Geography: The global AI in drug discovery market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Artificial Intelligence (AI) In Drug Discovery Market At:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-drug-discovery-global-market-report-2020-30-covid-19-growth-and-change

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in drug discovery market overviews, analyzes and forecasts market size and growth for the global artificial intelligence (AI) in drug discovery market, artificial intelligence (AI) in drug discovery market share, artificial intelligence (AI) in drug discovery market players, artificial intelligence (AI) in drug discovery market segments and geographies, artificial intelligence (AI) in drug discovery market’s leading competitors’ revenues, profiles and market shares. The artificial intelligence (AI) in drug discovery market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.